# FOcal RECurrent Assessment and Salvage Treatment

Source: https://onco.cc/trials/nct01883128/  
OnCo record `nct01883128` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Whole-body MRI in Prostate cancer, run by University College London Hospitals, with a status the registry has not verified recently.

## Summary

FOcal RECurrent Assessment and Salvage Treatment is a phase 2 interventional study registered as NCT01883128 by University College London Hospitals, with 177 participants planned, started 2014-04 and due to reach its primary completion in 2019-10. Interventions recorded: Whole Body MRI, Focal Salvage Therapy, MRI Targeted biopsies. Conditions recorded: Progression of Prostate Cancer.

Linked to the technology Whole-body MRI because the registry names it ("whole body mri") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01883128
- Phase: 2
- Setting: An Evaluation of a Novel Imaging Based Complex Diagnostic and Therapeutic Pathway Intervention for Men Who Fail Radiotherapy for Prostate Cancer.
- Sponsor: University College London Hospitals
- Enrolled: 177

## Sources

- ClinicalTrials.gov NCT01883128: https://clinicaltrials.gov/study/NCT01883128

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- technologies: [Whole-body MRI](https://onco.cc/technologies/whole-body-mri/)

---
JSON: https://onco.cc/api/v1/entities/nct01883128.json